NO330030B1 - Fremgangsmate for fremstilling av syklo(Arg-Gly-Asp-DPhe-NMeVal), samt rettkjedede pentapeptider som mellomprodukter i syntesen av syklo(Arg-Gly-Asp-DPhe-NMeVal). - Google Patents

Fremgangsmate for fremstilling av syklo(Arg-Gly-Asp-DPhe-NMeVal), samt rettkjedede pentapeptider som mellomprodukter i syntesen av syklo(Arg-Gly-Asp-DPhe-NMeVal). Download PDF

Info

Publication number
NO330030B1
NO330030B1 NO20014383A NO20014383A NO330030B1 NO 330030 B1 NO330030 B1 NO 330030B1 NO 20014383 A NO20014383 A NO 20014383A NO 20014383 A NO20014383 A NO 20014383A NO 330030 B1 NO330030 B1 NO 330030B1
Authority
NO
Norway
Prior art keywords
nmeval
dphe
asp
arg
gly
Prior art date
Application number
NO20014383A
Other languages
English (en)
Norwegian (no)
Other versions
NO20014383L (no
NO20014383D0 (no
Inventor
Alfred Jonczyk
Markus Arnold
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20014383D0 publication Critical patent/NO20014383D0/no
Publication of NO20014383L publication Critical patent/NO20014383L/no
Publication of NO330030B1 publication Critical patent/NO330030B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • C07K5/06095Arg-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0819Tripeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20014383A 1999-03-11 2001-09-10 Fremgangsmate for fremstilling av syklo(Arg-Gly-Asp-DPhe-NMeVal), samt rettkjedede pentapeptider som mellomprodukter i syntesen av syklo(Arg-Gly-Asp-DPhe-NMeVal). NO330030B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19910727 1999-03-11
PCT/EP2000/001751 WO2000053627A1 (de) 1999-03-11 2000-03-01 VERFAHREN ZUR HERSTELLUNG VON CYCLO-(Asp-DPhe-NMeVal-Arg-Gly)

Publications (3)

Publication Number Publication Date
NO20014383D0 NO20014383D0 (no) 2001-09-10
NO20014383L NO20014383L (no) 2001-11-02
NO330030B1 true NO330030B1 (no) 2011-02-07

Family

ID=7900511

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014383A NO330030B1 (no) 1999-03-11 2001-09-10 Fremgangsmate for fremstilling av syklo(Arg-Gly-Asp-DPhe-NMeVal), samt rettkjedede pentapeptider som mellomprodukter i syntesen av syklo(Arg-Gly-Asp-DPhe-NMeVal).

Country Status (28)

Country Link
US (1) US6822074B1 (uk)
EP (1) EP1159296B1 (uk)
JP (1) JP4762418B2 (uk)
KR (1) KR100645002B1 (uk)
CN (1) CN1200947C (uk)
AR (1) AR022905A1 (uk)
AT (1) ATE267839T1 (uk)
AU (1) AU762540B2 (uk)
BR (1) BR0008863A (uk)
CA (1) CA2366694C (uk)
CZ (1) CZ299879B6 (uk)
DE (1) DE50006598D1 (uk)
DK (1) DK1159296T3 (uk)
ES (1) ES2221616T3 (uk)
HK (1) HK1044780B (uk)
HU (1) HUP0200369A3 (uk)
ID (1) ID30126A (uk)
MY (1) MY120083A (uk)
NO (1) NO330030B1 (uk)
PL (1) PL202996B1 (uk)
PT (1) PT1159296E (uk)
RU (1) RU2243974C2 (uk)
SE (1) SE1159296T5 (uk)
SK (1) SK285387B6 (uk)
TW (1) TWI269798B (uk)
UA (1) UA71608C2 (uk)
WO (1) WO2000053627A1 (uk)
ZA (1) ZA200108335B (uk)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0814519D0 (en) 2008-08-08 2008-09-17 Imp Innovations Ltd Process
WO2010130030A1 (en) * 2009-05-15 2010-11-18 National Research Counsil Of Canada Dna sequences encoding caryophyllaceae and caryophyllaceae-like cyclopeptide precursors and methods of use
MX2011012231A (es) * 2009-05-20 2011-12-08 Merck Patent Gmbh Nuevos materiales solidos del {acido[(2s.5r,8s,11s)-5-bencil-11-(3 -guanidino-propil)-8-isopropil-7-metil-3,6,9,12,15-pentaoxi-1,4,7 ,10,13-pentaaza-ciclopentadec-2-il]-acetico} y metodos para obtenerlos.
EA022700B1 (ru) 2009-12-10 2016-02-29 Мерк Патент Гмбх Фармацевтическая композиция, содержащая олигопептиды
CN103717205B (zh) 2011-06-09 2017-04-12 默克专利股份公司 用西仑吉肽在载体中的悬浮液治疗癌症和癌症转移
US11753440B2 (en) * 2018-06-05 2023-09-12 Dsm Ip Assets B.V. Methods for the synthesis of arginine-containing peptides

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1038741B (de) * 1956-09-14 1958-09-11 Eberhard Brecklinghaus Aus Gummi oder einem anderen elastischen Werkstoff bestehender Kantenschoner fuer Treppenstufen aus Beton od. dgl.
US3630660A (en) * 1968-10-31 1971-12-28 Burlington Industries Inc Process for removal of moisture and/or solvents from textile materials
UA43823C2 (uk) * 1992-07-06 2002-01-15 Мерк Патент Геселлшафт Міт Бесшренктер Хафтунг ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ІНТЕГРИН <font face="Symbol">a</font><sub>V</sub><font face="Symbol">b</font><sub>3</sub>-ОПОСЕРЕДКОВАНОЇ КЛІТИННОЇ АДГЕЗІЇ КЛІТИН ССАВЦІВ, СПОСІБ ЛІКУВАННЯ ТА ПРОФІЛАКТИКИ ЗАХВОРЮВАННЯ, АСОЦІЙОВАНОГО З ПОРУШЕННЯМ АДГЕЗІЇ КЛІТИН, СПОСІБ БЛОКУВАННЯ ЗВ'ЯЗУВАННЯ ФІБРИНОГЕНОМ ІНТЕГРИНУ, КОМПОЗИЦІЯ ДЛЯ ЗАГОЄННЯ РАН
JPH06263798A (ja) * 1993-01-13 1994-09-20 Takeda Chem Ind Ltd βターン及びγターンを有する環状ペンタペプチド、その製造方法および用途
EP0606881B1 (en) * 1993-01-13 1999-05-12 Takeda Chemical Industries, Ltd. Cyclic pentapeptides having a beta-turn and a gamma-turn
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
ATE226960T1 (de) * 1994-06-02 2002-11-15 Forssmann Wolf Georg Verfahren zur herstellung von cardiodilatin- fragmenten, hochgereinigte cardiodilatin- fragmente und zwischenprodukte zu deren herstellung
DE19534177A1 (de) 1995-09-15 1997-03-20 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
DE19538741A1 (de) 1995-10-18 1997-04-24 Merck Patent Gmbh Cyclopeptidderivate
DE19613933A1 (de) 1996-04-06 1997-10-09 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
CZ380098A3 (cs) * 1996-05-31 1999-05-12 The Scripps Research Institute Způsoby, výrobky, farmaceutické látky a alfa v beta5 antagonisté, vhodní pro inhibici angiogeneze řízené alfa v beta5
DE19728524A1 (de) * 1997-07-04 1999-01-07 Merck Patent Gmbh Cyclische Azapeptide

Also Published As

Publication number Publication date
SE1159296T5 (uk) 2004-09-07
CN1200947C (zh) 2005-05-11
ZA200108335B (en) 2003-01-10
ID30126A (id) 2001-11-08
CZ299879B6 (cs) 2008-12-17
UA71608C2 (en) 2004-12-15
KR100645002B1 (ko) 2006-11-10
KR20010102503A (ko) 2001-11-15
NO20014383L (no) 2001-11-02
EP1159296A1 (de) 2001-12-05
BR0008863A (pt) 2002-01-02
DE50006598D1 (de) 2004-07-01
HK1044780B (zh) 2005-08-26
TWI269798B (en) 2007-01-01
RU2243974C2 (ru) 2005-01-10
MY120083A (en) 2005-08-30
ATE267839T1 (de) 2004-06-15
JP2002539137A (ja) 2002-11-19
AR022905A1 (es) 2002-09-04
SK285387B6 (sk) 2006-12-07
WO2000053627A1 (de) 2000-09-14
CN1343220A (zh) 2002-04-03
HK1044780A1 (en) 2002-11-01
SE1159296T3 (uk) 2004-08-24
HUP0200369A3 (en) 2002-09-30
NO20014383D0 (no) 2001-09-10
DK1159296T3 (da) 2004-09-27
US6822074B1 (en) 2004-11-23
ES2221616T3 (es) 2005-01-01
SK12552001A3 (sk) 2002-05-09
CA2366694A1 (en) 2000-09-14
AU762540B2 (en) 2003-06-26
AU4103400A (en) 2000-09-28
PL202996B1 (pl) 2009-08-31
CA2366694C (en) 2010-07-20
CZ20013214A3 (cs) 2001-12-12
EP1159296B1 (de) 2004-05-26
PT1159296E (pt) 2004-10-29
JP4762418B2 (ja) 2011-08-31
HUP0200369A2 (en) 2002-06-29

Similar Documents

Publication Publication Date Title
AU2010241171B2 (en) Method for the manufacture of degarelix
US9346850B2 (en) Method of producing peptide
EP1735345B1 (en) Processes for preparing eptifibatide and pertinent intermediate compounds
RU2602042C2 (ru) Способ производства дегареликса и его промежуточных соединений
EP2181118A1 (en) Process for the production of pramlintide
US9850285B2 (en) Process for preparing eptifibatide
EP3613757A1 (en) Solution phase routes for wnt hexapeptides
NO330030B1 (no) Fremgangsmate for fremstilling av syklo(Arg-Gly-Asp-DPhe-NMeVal), samt rettkjedede pentapeptider som mellomprodukter i syntesen av syklo(Arg-Gly-Asp-DPhe-NMeVal).
WO2023212841A1 (en) A kind of polypeptide analog with hair growth effect
MXPA01009111A (es) Procedimiento para preparar ciclo (asp-dfen-nmeval-arg-gli)
HU191414B (en) Process for preparing vasopressine analogues with antagonistic activity

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees